• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Committee for New Health Technology Assessment (CNHTA) [Sialendoscopy]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of video EEG for the assessment of patients with refractory epilepsy]
2011     HAYES, Inc. Leri-weill dyschondrosteosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Pro-BNP peptide in the diagnosis and prognosis of heart failure]
2011     University of York Supporting women with postnatal depression through psychological therapies
2011     The Swedish Council on Health Technology Assessment (SBU) [Bleeding peptic ulcer]
2011     Committee for New Health Technology Assessment (CNHTA) [Debridement using hydrosurgery system]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic mucosectomy for the treatment of sessile polyps ]
2011     HAYES, Inc. Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for post-menopausal osteoporosis – first or second line
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Abiraterone acetate (ZytigaTM) as 2nd-line therapy for the treatment of metastatic castration-resident prostate cancer after docetaxel therapy
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Treatment of benign prostatic hypertrophy - Barreiro method]
2011     University of York Evidence briefing on specialist nurses in acute hospital settings
2011     Committee for New Health Technology Assessment (CNHTA) [Camera manipulating robot assisted endoscopic surgery]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Effectiveness of eculizumab in the treatment of paroxysmal nocturnal hemoglobinuria]
2011     HAYES, Inc. Canaloplasty (iTrack 250A canaloplasty microcatheter; iScience Interventional Inc.) for primary open-angle glaucoma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2011     University of York Evidence briefing on nurse endoscopy
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on borderline personality disorders]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Toric intraocular lenses]
2011     HAYES, Inc. CellSearch circulating tumor cell (CTC) kit (Veridex LLC) for monitoring metastatic breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for relapsing-remitting multiple sclerosis
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity modulated radiation therapy for three dimensional breast cancer]
2011     University of York Evidence briefing on integrated care pathways in mental health settings
2011     Committee for New Health Technology Assessment (CNHTA) [Transanal radiofrequency treatment of fecal incontinence]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Electrical stimulation devices to treat delayed unions and pseudarthrosis]
2011     HAYES, Inc. C-leg prosthesis (Otto Bock HealthCare LP)
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lacosamide (Vimpat) for epilepsy – first and second line
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Botulinum toxin for the treatment of headache]
2011     The Swedish Council on Health Technology Assessment (SBU) [Benign Prostatic Obstruction (BPO)]
2011     Committee for New Health Technology Assessment (CNHTA) [autologous platelet rich plasma application]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of prometheus in severe liver failure]
2011     HAYES, Inc. CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Virtual hysterosalpingograghy to evaluate the uterus and tubes patency]
2011     Committee for New Health Technology Assessment (CNHTA) [HBV entecavir resistance mutation [PCR-RFMP]]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2011     HAYES, Inc. Cooled radiofrequency denervation of the sacroiliac joint (pain management sInergy system, Baylis Medical Co. Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of the methodological instruments used in Health Technology Assessment
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Drug-eluting balloon for the treatment of coronary stenosis]
2011     HAYES, Inc. EsophyX system with srosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011     Committee for New Health Technology Assessment (CNHTA) [BRAF Gene, Mutation(Peptide Nucleic Acid Mediated Real-time PCR Clamping Method)]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Robotic gynecological surgery]
2011     HAYES, Inc. Exhaled breath condensate pH testing for asthma management
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Real time intraoperative magnetic resonance imaging monitoring]
2011     HAYES, Inc. Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous acrylic vertebroplasty for the treatment of vertebral fractures]
2011     HAYES, Inc. eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Dalfampridine (ampyra) in multiple sclerosis patients]
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness, and guidelines
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Training therapy in physical medicine – Systematic Review]
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) [Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2011     Committee for New Health Technology Assessment (CNHTA) [I-125 permanent implant for prostate cancer]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Microdebrider in nose-throat surgeries]
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination therapy for pulmonary arterial hypertension: a review of the clinical effectiveness
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Exercise therapy (Krankengymnastik / Heilgymnastik) in physical medicine]
2011     Institute for Clinical and Economic Review (ICER) Management options for low back disorders
2011     Committee for New Health Technology Assessment (CNHTA) [Non-invasive cardiac output monitoring by bioreactance technology]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [The coblation technique in tonsillectomy]
2011     HAYES, Inc. Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2011     Committee for New Health Technology Assessment (CNHTA) [Enterovirus real-time rt-pcr]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab for pre-treated patients with advanced/metastatic melanoma
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Dabigatran and rivaroxaban as thrombophylaxis after major orthopedic surgery]
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein test]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nilotinib (Tasigna) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Rational use of self-monitoring of blood glucose in type 1 diabetes]
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Eliglustat tartrate, miglustat, imiglucerase, velaglucerase or a combination of these for the treatment of Gaucher disease: a review of clinical effectiveness and safety
2011     Committee for New Health Technology Assessment (CNHTA) [Deletion of 18q choromosome in colorectal cancer (LOH, loss of heterozygosity)]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cabazitaxel (Jevtana) for the second-line therapy of patients with hormone-refractory metastatic prostate cancer
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011     Committee for New Health Technology Assessment (CNHTA) [Photodynamic therapy for bladder, cervix and lung cancer]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Annual Report 2010. German version.]
2011     HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011     The Regional Health Technology Assessment Centre (HTA-centrum) [Surgical stabilization of a flail chest wall]
2011     Committee for New Health Technology Assessment (CNHTA) [C-11-acetate positron emission tomography, positron emission tomography/computed tomography]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annual Report 2010. English version
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011     HAYES, Inc. Provenge (Dendreon Corp.) vaccine for treatment of prostate cancer